These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 8529056
1. Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertension. Kuchel O, Shigetomi S. Hypertens Res; 1995 Jun; 18 Suppl 1():S183-5. PubMed ID: 8529056 [Abstract] [Full Text] [Related]
2. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency. Kuchel OG, Shigetomi S. Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367 [Abstract] [Full Text] [Related]
3. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable. Shigetomi S, Kuchel O. Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659 [Abstract] [Full Text] [Related]
4. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients. Kuchel O, Shigetomi S. Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460 [Abstract] [Full Text] [Related]
6. [Dopamine and hypertension]. Sigetomi S, Fukuchi S. Nihon Naibunpi Gakkai Zasshi; 1993 Oct 20; 69(9):953-62. PubMed ID: 8262273 [Abstract] [Full Text] [Related]
7. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. Cumming P, Ase A, Laliberté C, Kuwabara H, Gjedde A. J Cereb Blood Flow Metab; 1997 Nov 20; 17(11):1254-60. PubMed ID: 9390657 [Abstract] [Full Text] [Related]
8. Urinary dopamine and renal handling of L-DOPA in fasted spontaneously hypertensive rats. Dantonello TM, Küster E, Mühlbauer B. Kidney Blood Press Res; 1998 Nov 20; 21(6):438-44. PubMed ID: 9933829 [Abstract] [Full Text] [Related]
9. The decarboxylation of DOPA in the parkinsonian brain: in vivo studies on an animal model. Hefti F, Melamed E, Wurtman RJ. J Neural Transm Suppl; 1980 Nov 20; (16):95-101. PubMed ID: 6776238 [Abstract] [Full Text] [Related]
10. Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man. Williams M, Young JB, Rosa RM, Gunn S, Epstein FH, Landsberg L. J Clin Invest; 1986 Dec 20; 78(6):1687-93. PubMed ID: 3097077 [Abstract] [Full Text] [Related]
11. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L. Srp Arh Celok Lek; 2002 Dec 20; 130(3-4):73-80. PubMed ID: 12154518 [Abstract] [Full Text] [Related]
16. Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney. Suzuki H, Nakane H, Kawamura M, Yoshizawa M, Takeshita E, Saruta T. Am J Physiol; 1984 Sep 20; 247(3 Pt 1):E285-90. PubMed ID: 6433718 [Abstract] [Full Text] [Related]
17. Derivation of urinary dopamine from plasma dopa. Zimlichman R, Levinson PD, Kelly G, Stull R, Keiser HR, Goldstein DS. Clin Sci (Lond); 1988 Nov 20; 75(5):515-20. PubMed ID: 3151165 [Abstract] [Full Text] [Related]
18. Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure. Fukuda S, Kobayashi H, Mochizuki T, Tanaka M, Yokoyama Y, Hattori N. Nihon Jinzo Gakkai Shi; 1992 Sep 20; 34(9):1011-7. PubMed ID: 1479729 [Abstract] [Full Text] [Related]
19. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma. Ikeda H, Matsuyama S, Suzuki N, Takahashi A, Kuroiwa M. Hypertens Res; 1995 Jun 20; 18 Suppl 1():S209-10. PubMed ID: 8529065 [Abstract] [Full Text] [Related]
20. Reduced venous responsiveness to endothelin-1 but not noradrenaline in hypertensive chronic renal failure. Hand MF, Haynes WG, Webb DJ. Nephrol Dial Transplant; 2001 Feb 20; 16(2):295-301. PubMed ID: 11158403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]